EDMOND DE ROTHSCHILD PRIVATE EQUITY
The Edmond de Rothschild Group is a leader in private equity, using its family experience to assist companies. Their teams are not merely financial investors. They are active partners in company growth and work closely with company executives on value creation. Their Group has long understood that taking environmental, social and governance (ESG) issues into consideration is key to both risk management and value creation for all of the companies in its portfolio. Each area of expertise applies considerations from outside the realm of finance to its specific investment strategy and implements the highest ESG standards.
EDMOND DE ROTHSCHILD PRIVATE EQUITY
Industry:
Asset Management Financial Services Risk Management
Founded:
1953-01-01
Status:
Active
Contact:
+33 1 40 17 25 52
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Mobile Non Scaleable Content ASP.NET Ajax GlobalSign Microsoft Office SharePoint
Similar Organizations
Systematica Investments
Systematica Investments is provides hedge fund investment services.
Wendel
Wendel is a strong tradition of entrepreneurship supporting long-term investing.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-02 | Sapore Di Mare | Sapore Di Mare acquired by Edmond de Rothschild Private Equity | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-05 | Swiss Summit Capital | Edmond de Rothschild Private Equity investment in Series A - Swiss Summit Capital | 23.7 M CHF |
| 2017-10-01 | Philogeris Group | Edmond de Rothschild Private Equity investment in Venture Round - Philogeris Group | N/A |
| 2017-01-01 | Avalyn Pharma | Edmond de Rothschild Private Equity investment in Series A - Avalyn Pharma | 62 M USD |
| 2016-06-15 | Allecra Therapeutics | Edmond de Rothschild Private Equity investment in Series B - Allecra Therapeutics | 22 M EUR |
| 2015-01-07 | Genkyotex | Edmond de Rothschild Private Equity investment in Post-IPO Equity - Genkyotex | 20 M CHF |
| 2013-12-09 | Covagen | Edmond de Rothschild Private Equity investment in Series B - Covagen | 58.9 M CHF |
| 2013-08-07 | OncoEthix | Edmond de Rothschild Private Equity investment in Series B - OncoEthix | 18 M CHF |
| 2013-04-18 | Allecra Therapeutics | Edmond de Rothschild Private Equity investment in Series A - Allecra Therapeutics | 15 M EUR |
| 2011-02-16 | Sergeant Major | Edmond de Rothschild Private Equity investment in Private Equity Round - Sergeant Major | 32 M EUR |
| 2009-03-05 | GlycoVaxyn | Edmond de Rothschild Private Equity investment in Series B - GlycoVaxyn | 17 M EUR |